Does RANIBIZUMAB Cause Disease recurrence? 157 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 157 reports of Disease recurrence have been filed in association with RANIBIZUMAB (CIMERLI). This represents 1.0% of all adverse event reports for RANIBIZUMAB.
157
Reports of Disease recurrence with RANIBIZUMAB
1.0%
of all RANIBIZUMAB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Disease recurrence From RANIBIZUMAB?
Of the 157 reports, 3 (1.9%) required hospitalization.
Is Disease recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 157 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Disease recurrence?
NIRMATRELVIR\RITONAVIR (20,040)
PREDNISONE (1,979)
CYCLOPHOSPHAMIDE (1,689)
RITUXIMAB (1,588)
METHOTREXATE (1,401)
DOXORUBICIN (980)
VINCRISTINE (932)
PREDNISOLONE (873)
MYCOPHENOLATE MOFETIL (852)
DEXAMETHASONE (784)
Which RANIBIZUMAB Alternatives Have Lower Disease recurrence Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE